Evidence map›Paper›PMID 29953474›Full record

ArticlePloS one2018

Comparison of chikungunya viruses generated using infectious clone or the Infectious Subgenomic Amplicons (ISA) method in Aedes mosquitoes.

Souand Mohamed Ali, Anubis Vega-Rúa, Jean-Sélim Driouich, Xavier de Lamballerie, Anna-Bella Failloux, Antoine Nougairède

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Souand Mohamed AliUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190 -Inserm 1207 -IHU Méditerranée Infection), Marseille, France.
Anubis Vega-RúaDepartment of Virology, Arboviruses and Insect Vectors, Institut Pasteur, Paris, France.
Jean-Sélim DriouichUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190 -Inserm 1207 -IHU Méditerranée Infection), Marseille, France.
Xavier de LamballerieUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190 -Inserm 1207 -IHU Méditerranée Infection), Marseille, France.
Anna-Bella FaillouxDepartment of Virology, Arboviruses and Insect Vectors, Institut Pasteur, Paris, France.
Antoine NougairèdeUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190 -Inserm 1207 -IHU Méditerranée Infection), Marseille, France.ORCID 0000-0001-7729-2636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reverse genetics systems provide the opportunity to manipulate viral genomes and have been widely used to study RNA viruses and to develop new antiviral compounds and vaccine strategies. The recently described method called ISA (Infectious Subgenomic Amplicons) gives the possibility to rescue RNA viruses in days. We demonstrated in cell culture that the use of the ISA method led to a higher genetic diversity of viral populations than that observed using infectious clone technology. However, no replicative fitness difference was observed. In the present study, we used the chikungunya virus as a model to compare in Aedes aegypti and Aedes albopictus mosquitoes the genotypic and phenotypic characteristics of viruses produced either from an infectious clone or using the ISA method. We confirmed the results found in cellulo corroborating that the use of the ISA method was associated with higher genetic diversity of viral populations in mosquitoes but did not affect the vector competence validating its use for in vivo experiments.

Indexed as

Genome, ViralRNA, ViralAedesAnimalsBiological EvolutionChikungunya virusChlorocebus aethiopsFemaleGenetic VariationVero CellsRNA, Viral

Identifiers

PMID29953474
PMCPMC6023229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.